NCT07202689

Brief Summary

Postoperative stroke following cardiac surgery is associated with a ninefold increase in mortality risk compared to patients without stroke. Perioperative monitoring in cardiac surgery involves a range of complex and diverse techniques, presenting significant challenges for anesthetic management. Multimodal brain monitoring technology offers a novel approach to cerebral protection during the perioperative period of cardiac surgery by integrating hemodynamic parameters, autonomic nervous responses, cerebral oxygen saturation and indices, electroencephalographic activity, and cerebral blood flow velocity. Therefore, this study aims to evaluate the comprehensive early-warning efficacy of multimodal brain monitoring for perioperative stroke in cardiac surgery patients, determine the cumulative incidence of perioperative stroke-including covert stroke-and provide a new theoretical basis for optimizing cerebral protection strategies in cardiac surgery.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
369

participants targeted

Target at P75+ for all trials

Timeline
33mo left

Started Oct 2025

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
Oct 2025Dec 2028

First Submitted

Initial submission to the registry

September 24, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 2, 2025

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2028

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

October 2, 2025

Status Verified

September 1, 2025

Enrollment Period

3.2 years

First QC Date

September 24, 2025

Last Update Submit

September 24, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The incidence of perioperative stroke

    Perioperative stroke is diagnosed by MRI

    48 hours preoperatively and 3-7 days postoperatively

Study Arms (2)

With stroke

Device: Multimodal monitoring

Without stroke

Device: Multimodal monitoring

Interventions

Multimodal monitoring technology offers a novel approach to cerebral protection during the perioperative period of cardiac surgery by integrating hemodynamic parameters, autonomic nervous responses, cerebral oxygen saturation and indices, electroencephalographic activity, and cerebral blood flow velocity.

With strokeWithout stroke

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The population will be selected from patients who schedule to receive elective cardiac surgery in Beijing Tiantan Hospital.

You may qualify if:

  • Patients scheduled for elective cardiac surgery
  • Presence of at least one of the following high-risk factors for stroke: a.Peripheral vascular disease (history of peripheral artery bypass grafting, amputation for ischemia, Ankle-Brachial Pressure Index \< 0.9, or history of abdominal aortic aneurysm repair).b.Cerebrovascular disease (history of stroke, transient ischemic attack, or carotid stenosis \>70%).c.Renal insufficiency (Glomerular Filtration Rate \< 60 mL/min/1.73m²).d.Diabetes mellitus (requiring oral hypoglycemic agents and/or insulin therapy).e.Urgent coronary artery bypass grafting (inpatient requiring revascularization due to acute coronary syndrome or myocardial infarction).f.Recent smoking history (within 1 year).g.Left ventricular ejection fraction \< 35%
  • Provision of signed informed consent

You may not qualify if:

  • Contraindication to magnetic resonance imaging (e.g., claustrophobia, inability to lie flat for the duration of the study, presence of a pacemaker or implantable cardioverter-defibrillator, or other metallic implants)
  • Inability to complete cognitive function assessments
  • Patients with psychiatric, legal disabilities or under legal guardianship
  • Life expectancy of less than 3 months
  • Women who are lactating or pregnant
  • Diagnosis of any type of dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Yuming Peng, MD,Ph.D

    Beijing Tiantan Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yuming Peng, MD,Ph.D

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy chief of Department of Anesthesiology

Study Record Dates

First Submitted

September 24, 2025

First Posted

October 2, 2025

Study Start

October 1, 2025

Primary Completion (Estimated)

November 30, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

October 2, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share